HomeNewsMeasurement of CT attenuation values for predicting tumor necrosis following lenvatinib treatment in patients with HCC

Measurement of CT attenuation values for predicting tumor necrosis following lenvatinib treatment in patients with HCC

A recent study aimed to determine threshold CT attenuation values helpful for predicting tumor necrosis in patients with hepatocellular carcinoma (HCC) who obtained a complete response following lenvatinib treatment. An optimal cut-off attenuation value was identified that proved to be highly sensitive and moderately specific in differentiating between HCC necrosis and degeneration after treatment.